相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Preclinical toxicity and pharmacokinetics of a new orally bioavailable flubendazole formulation and the impact for clinical trials and risk/benefit to patients
Sophie Lachau-Durand et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Flubendazole as a macrofilaricide: History and background
Timothy G. Geary et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease
Gemma L. Nixon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
The metabolism of flubendazole in human liver and cancer cell lines
Lucie Raisova Stuchlikova et al.
DRUG TESTING AND ANALYSIS (2018)
Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition
Eunhye Oh et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Flubendazole induces mitotic catastrophe and apoptosis in melanoma cells
K. Canova et al.
TOXICOLOGY IN VITRO (2018)
Flubendazole and mebendazole impair migration and epithelial to mesenchymal transition in oral cell lines
Vera Kralova et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
The role of carbonyl reductase 1 in drug discovery and development
Sophia M. Shi et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
Species differences in hepatic biotransformation of the anthelmintic drug flubendazole
M. L. Mate et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2017)
Perspectives of Benzimidazole Derivatives as Anticancer Agents in the New Era
Snehlata Yadav et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2016)
Flubendazole induces mitotic catastrophe and senescence in colon cancer cells in vitro
Vera Kralova et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2016)
Potential Anti-cancer Drugs Commonly Used for Other Indications
Veronika Hanusova et al.
CURRENT CANCER DRUG TARGETS (2015)
The modulation of carbonyl reductase 1 by polyphenols
Iva Bousova et al.
DRUG METABOLISM REVIEWS (2015)
Structure-activity relationship of flavonoids as potent inhibitors of carbonyl reductase 1 (CBR1)
Yuki Arai et al.
FITOTERAPIA (2015)
Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screen
Martin Michaelis et al.
SCIENTIFIC REPORTS (2015)
Pharmacokinetic comparison of different flubendazole formulations in pigs: A further contribution to its development as a macrofilaricide molecule
L. Ceballos et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2015)
Antiproliferative effect of benzimidazole anthelmintics albendazole, ricobendazole, and flubendazole in intestinal cancer cell lines
Vera Kralova et al.
ANTI-CANCER DRUGS (2013)
Anthracyclines and their metabolism in human liver microsomes and the participation of the new microsomal carbonyl reductase
Adam Skarka et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2011)
Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs
Charles D. Mackenzie et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma
Paul A. Spagnuolo et al.
BLOOD (2010)
The effects of flubendazole and its metabolites on the larval development of Haemonchus contortus (Nematoda: Trichostrongylidae): an in vitro study
H. Bartikova et al.
HELMINTHOLOGIA (2010)
Pharmacokinetics of flubendazole and its metabolites in lambs and adult sheep (Ovis aries)
V. Krizova et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2009)
Hepatic and extra-hepatic metabolic pathways involved in flubendazole biotransformation in sheep
Laura Mate et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Sensitive chiral high-performance liquid chromatographic determination of anthelmintic flubendazole and its phase I metabolites in blood plasma using UV photodiode-array and fluorescence detection Application to pharmacokinetic studies in sheep
Milan Nobilis et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2008)
Inhibition of polymorphic human carbonyl reductase 1 (CBR1) by the cardioprotectant flavonoid 7-monohydroxyethyl rutoside (monoHER)
Vanessa Gonzalez-Covarrubias et al.
PHARMACEUTICAL RESEARCH (2008)
分享论文
